Dr. Marion Gruber, director of the FDA’s vaccines office, will quit at the end of October, and her deputy, Dr. Philip Krause, will leave in November because the White House has overstepped its mark by pressing ahead with what they deem to be an unscientific Covid-19 booster jab campaign.
The pair have accused the White House and CDC of pushing booster shots without supporting data, and are said to be frustrated that the CDC and their ACIP committee are involved in decisions that they think should be up to the Food and Drig Administration (FDA).
Marion Gruber is the director of the FDA’s Office of Vaccines Research & Review and has been with the agency for 32 years, whilst OVRR deputy director Phil Krause, has been at the FDA for more than a decade.
FDA’s former acting chief scientist Luciana Borio said on Twitter that the “FDA is losing two giants who helped bring us many safe and effective vaccines over decades of public service.”
— Luciana Borio, MD (@llborio) August 31, 2021
The Director of Centre for Biologics Evaluation and Research sent a letter to FDA staff confirming the resignations in which he wrote that “It is with mixed feelings that I have the news of two retirements… Our search for the next office director will begin imminently”.